Gut Liver. 2014;8(3):254-64.
Recent chemotherapy reduces the maximum-standardized uptake value of 18F-fluoro-deoxyglucose positron emission tomography in colorectal cancer.
제1저자 이민종 · 교신저자 김지원
소속 (3)
- Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul, Korea, Departments of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Departments of Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Abstract
BACKGROUND/AIMS The aim of this study was to evaluate the influence of recent chemotherapy on the patterns of the maximum-standardized uptake value (M-SUV) and sensitivity of (18)F-fluoro-deoxyglucose positron emission tomography/computed tomography ((18)F-FDG-PET/CT) in colorectal cancer.
METHODS We retrospectively analyzed the FDG-PET/CT of 509 patients who underwent surgery for colorectal cancer. Subgroup analysis was performed according to chemotherapy status; 401 patients were not treated with chemotherapy and 108 patients were treated with chemotherapy within 6 months prior to surgery. Pathologic analysis of the surgical specimen was used as the gold standard.
RESULTS The M-SUV was significantly lower in patients treated with chemotherapy than in those not treated with chemotherapy in pathologically confirmed same stages of disease. The difference in the sensitivity of the M-SUV according to chemotherapy status was greatest using a cutoff M-SUV value of 6.4 (p<0.001). The longest diameter of the primary tumor was the most important factor that correlated with M-SUV of the primary tumor irrespective of the chemotherapy effect (p<0.001). The M-SUV of the primary tumor was not an independent predictor of lymph node metastasis in colorectal cancer.
CONCLUSIONS The results indicate that the M-SUV of FDG-PET/CT should be interpreted in the context of concurrent chemotherapy.
Keywords
Colorectal neoplasmsDrug therapyFDG-PET/CT
Figures
그림 출처: PubMed Central 공개 논문 (PMC4026642)
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
그 밖의 정보
- 출판 형태
- Journal Article
- 저널
- Gut and liver · eISSN 2005-1212
- MeSH
- Aged · Antineoplastic Agents / adverse effects · Chemoradiotherapy, Adjuvant / adverse effects · Chemotherapy, Adjuvant / adverse effects · Colorectal Neoplasms / diagnostic imaging / drug therapy / pathology · Female · Fluorodeoxyglucose F18 / pharmacology · Humans · Male · Neoplasm Invasiveness · Neoplasm Metastasis · Positron-Emission Tomography / methods · Radiopharmaceuticals / pharmacology · Retrospective Studies
- Substances
- Antineoplastic Agents · Radiopharmaceuticals · Fluorodeoxyglucose F18
- 참고문헌
- 29편